# PF-04634817 Renal Impairment Study

> **NCT01791855** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 32 (actual)

## Conditions studied

- Renal Insufficiency

## Interventions

- **DRUG:** PF-04634817
- **DRUG:** PF-04634817
- **DRUG:** PF-04634817
- **DRUG:** PF-04634817

## Key facts

- **NCT ID:** NCT01791855
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-10
- **Primary completion:** 2013-09-03
- **Final completion:** 2013-09-03
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01791855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01791855, "PF-04634817 Renal Impairment Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01791855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*